Agenus completed the acquisition of CTC North.

Synopsis

Agenus, a biotechnology company, completed the acquisition of CTC North, a company which conducts clinical trials and provides suitable organizational support. Financial terms were not disclosed.

Principals

target

Ctc North

bidder

Agenus

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (4)

christina mann

Counsel at Latham & Watkins

Lawyer

bidder

Deals

£ 2.24 B

Total Value

peter handrinos

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 13.68 B

Total Value

christoph w. g. engeler

Partner at Latham & Watkins

Lawyer

bidder

Deals

£ 16.01 B

Total Value

garo h. armen

CEO at AGENUS INC

Manager

bidder

Deal

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy